Filing Details

Accession Number:
0000950170-24-139063
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-20 16:21:13
Reporting Period:
2024-12-19
Accepted Time:
2024-12-20 16:21:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783183 Phathom Pharmaceuticals Inc. PHAT Pharmaceutical Preparations (2834) 824151574
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791412 Azmi Nabulsi C/O Phathom Pharmaceuticals, Inc.
100 Campus Drive, Suite 102
Florham Pak NJ 07932
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-12-19 1,118 $8.00 239,303 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,579 Indirect By 401(k)
Common Stock 785,700 Indirect By Trust
Footnotes
  1. Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.